TY - JOUR
T1 - Test-retest reliability of pulse amplitude tonometry measures of vascular endothelial function
T2 - Implications for clinical trial design
AU - McCrea, Cindy E.
AU - Skulas-Ray, Ann C.
AU - Chow, Mosuk
AU - West, Sheila G.
PY - 2012/2
Y1 - 2012/2
N2 - Endothelial dysfunction is an important outcome for assessing vascular health in intervention studies. However, reliability of the standard non-invasive method (flow-mediated dilation) is a significant challenge for clinical applications and multicenter trials. We evaluated the repeatability of pulse amplitude tonometry (PAT) to measure change in pulse wave amplitude during reactive hyperemia (Itamar Medical Ltd, Caesarea, Israel). Twenty healthy adults completed two PAT tests (mean interval = 19.5 days) under standardized conditions. PAT-derived measures of endothelial function (reactive hyperemia index, RHI) and arterial stiffness (augmentation index, AI) showed strong repeatability (intra-class correlations = 0.74 and 0.83, respectively). To guide future research, we also analyzed sample size requirements for a range of effect sizes. A crossover design powered at 0.90 requires 28 participants to detect a 15% change in RHI. Our study is the first to show that PAT measurements are repeatable in adults over an interval greater than 1 week.
AB - Endothelial dysfunction is an important outcome for assessing vascular health in intervention studies. However, reliability of the standard non-invasive method (flow-mediated dilation) is a significant challenge for clinical applications and multicenter trials. We evaluated the repeatability of pulse amplitude tonometry (PAT) to measure change in pulse wave amplitude during reactive hyperemia (Itamar Medical Ltd, Caesarea, Israel). Twenty healthy adults completed two PAT tests (mean interval = 19.5 days) under standardized conditions. PAT-derived measures of endothelial function (reactive hyperemia index, RHI) and arterial stiffness (augmentation index, AI) showed strong repeatability (intra-class correlations = 0.74 and 0.83, respectively). To guide future research, we also analyzed sample size requirements for a range of effect sizes. A crossover design powered at 0.90 requires 28 participants to detect a 15% change in RHI. Our study is the first to show that PAT measurements are repeatable in adults over an interval greater than 1 week.
KW - EndoPAT
KW - experimental design
KW - peripheral arterial tonometry
KW - pulse amplitude tonometry
KW - reactive hyperemia index
KW - repeatability
KW - RHI
KW - test-retest reliability
UR - http://www.scopus.com/inward/record.url?scp=84857586491&partnerID=8YFLogxK
U2 - 10.1177/1358863X11433188
DO - 10.1177/1358863X11433188
M3 - Article
C2 - 22363016
AN - SCOPUS:84857586491
SN - 1358-863X
VL - 17
SP - 29
EP - 36
JO - Vascular Medicine
JF - Vascular Medicine
IS - 1
ER -